These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18234355)

  • 1. Effect of pharmacological treatment on temperament and character in panic disorder.
    Marchesi C; De Panfilis C; Cantoni A; Giannelli MR; Maggini C
    Psychiatry Res; 2008 Mar; 158(2):147-54. PubMed ID: 18234355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of temperament and character on response to selective serotonin reuptake inhibitors in panic disorder.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    Acta Psychiatr Scand; 2006 Sep; 114(3):203-10. PubMed ID: 16889591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    J Affect Disord; 2005 Dec; 89(1-3):189-94. PubMed ID: 16209891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?
    Mazza M; Mazza O; Pomponi M; Di Nicola M; Padua L; Vicini M; Bria P; Mazza S
    Compr Psychiatry; 2009; 50(3):240-4. PubMed ID: 19374968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.
    Boz C; Gazioglu S; Altunayoglu V; Hocaoglu C
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):534-42. PubMed ID: 17875033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.
    Tomita T; Kaneda A; Nakagami T; Kaneko S; Yasui-Furukori N
    Hum Psychopharmacol; 2015 Sep; 30(5):334-40. PubMed ID: 25845342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in anxiety sensitivity with pharmacotherapy for panic disorder.
    Simon NM; Otto MW; Smits JA; Nicolaou DC; Reese HE; Pollack MH
    J Psychiatr Res; 2004; 38(5):491-5. PubMed ID: 15380399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Character and temperament in major depressive disorder and a highly anxious-retarded subtype derived from melancholia.
    de Winter RF; Wolterbeek R; Spinhoven P; Zitman FG; Goekoop JG
    Compr Psychiatry; 2007; 48(5):426-35. PubMed ID: 17707250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperament and character dimensions of patients with adult separation anxiety disorder.
    Mertol S; Alkın T
    J Affect Disord; 2012 Jul; 139(2):199-203. PubMed ID: 22440427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine.
    Freire RC; Amrein R; Mochcovitch MD; Dias GP; Machado S; Versiani M; Arias-Carrión O; Carta MG; Nardi AE
    J Clin Psychopharmacol; 2017 Aug; 37(4):429-434. PubMed ID: 28609307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm avoidance and self-directedness as essential features of panic disorder patients.
    Wachleski C; Salum GA; Blaya C; Kipper L; Paludo A; Salgado AP; Manfro GG
    Compr Psychiatry; 2008; 49(5):476-81. PubMed ID: 18702933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.
    Marchesi C; De Panfilis C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1240-5. PubMed ID: 16678956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of personality factors on paroxetine response time in patients with major depression.
    Kaneda A; Yasui-Furukori N; Nakagami T; Sato Y; Kaneko S
    J Affect Disord; 2011 Dec; 135(1-3):321-5. PubMed ID: 21784533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder.
    Lee IS; Kim KJ; Kang EH; Yu BH
    J Affect Disord; 2008 Sep; 110(1-2):156-60. PubMed ID: 18199486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.